Condition: Heart Failure · Sponsor: Microtech Medical Technologies, Ltd
The Microtech-LVAD study is designed as a prospective, single arm, multi-center early feasibility study. Approximately 15 patients will be enrolled in the study. The study will be limited to patients in whom it is decided, based on routine clinical practice, that the LVAD will be implanted via a midline sternotomy. In the first 5 study patients, the device will be implanted in the RA; subsequently, the device will be implanted in the LA unless the patient is deemed at high risk of post-LVAD right heart failure, in which case the device will be placed in the RA
This description comes directly from the study's public registry record.
Brenda Koltun Reuven · +972542666688 · brendak@medinol.com
Always discuss trial participation with your own doctor first.
| Columbia University Medical Center/ NewYork Presbyterian Hospital or CUMC/NYPH | New York, New York, United States | Recruiting |
| Rabin Medical Center | Petach Tikvah, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06682910